Caldan Therapeutics
Develops innovative therapeutics targeting Type 2 Diabetes
Caldan Therapeutics has raised €6.3M across 1 funding round from 2 investors, most recently a Series A round in Nov 2015. Based in Glasgow, UK; active in Healthtech. Data as of 28 Oct 2026.
Glasgow, UK
Total raised
€6.3M
€6,265,664
Funding rounds
1
Investors
2
distinct backers
Active since
2015-11
latest 2015-11
Funding by year
EUR raised per yearCaldan Therapeutics — funding by year — interactive chart.
Data table
| Caldan Therapeutics — funding by year | |
|---|---|
| 2015 | €6.3M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2015-11-01 | Series A | €6.3M | Epidarex Capital,Scottish Investment Bank - Scottish Enterprise | View deal → |
Similar companies
same sector or countryGlobal coverage: FundingData